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Abstract
The study aims were: (i) to deﬁne the prevalence of and risk factors for colonization by extended spectrum b-lactamase (ESBL) -producing
Enterobacteriaceae (EPE) among healthcare workers (HCWs) and family members (FMs) of EPE-colonized patients in rehabilitation units and (ii)
to compare EPE isolates from these three groups. The study included 286 FMs of 194 EPE-carrying patients identiﬁed in ﬁve rehabilitation units
located in Israel, Italy, France and Spain. The EPE were detected in rectal swabs from 26 (9%) of 286 FMs screened. In multivariate analyses,
older age of FM, greater mean number of hours spent with the patient, being a daughter or a female spouse of a patient, and chronic lung disease
of the patient were signiﬁcantly associated with carriage in the FM. Escherichia coliwas the most common organism (76%), followed by Klebsiella
pneumoniae (19%). Isolates were typed by pulsed ﬁeld gel electrophoresis and multilocus sequence typing, and ESBLs were identiﬁed by PCR
sequencing. A comparison of paired species isolates from FMs and their respective patient showed that 17 of 23 strains were indistinguishable.
EPE were detected in 35 (3.5%, E. coli = 34) of the 1001 HCWs screened. Feeding patients was associated with EPE carriage by HCWs. Only 7
of 23 E. coli subclones cultured from HCWs were also represented among 376 patient-derived ESBL-producing E. coli isolates from the same
rehabilitation units. In Spain, a higher proportion of HCWs and FMs were ESBL carriers than elsewhere (p <0.05). In conclusion, the molecular
and epidemiological data suggest that FMs are at higher risk of EPE acquisition from their relative patients than HCWs.
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Introduction
Extended-spectrum b-lactamase (ESBL) -producing Enterobac-
teriaceae (EPE) are among the most common causes of
nosocomial infections and outbreaks [1]. Different species
[2] and clones [3] were found to possess different dissemina-
tion potential. In the last decade, EPE, speciﬁcally ESBL-pro-
ducing Escherichia coli, have also emerged as a source of
community-acquired infections [4,5]. One possible explanation
for this phenomenon is the transmission of EPE from
hospitalized patients to their caregivers, including healthcare
workers (HCWs) and family members (FMs). The latter may
occur either during or following hospitalization. This concept,
though widely accepted for Staphylococcus aureus [6–8], has
been studied in only a few published works [2,9–11], none of
which have combined the clinical and epidemiological risk
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factor analysis with the molecular comparative characteriza-
tion. In the present study, we examined EPE carriage among
HCWs and FMs of patients hospitalized in rehabilitation units
(RUs). The potential for direct transmission between patients
and HCWs in RUs may be remarkable and so they constitute
an excellent and so far under-exploited model for such a study.
We aimed to study the prevalence of EPE carriage in HCWs
and the FMs of patients, and to assess whether the EPE
carriage in these groups is related to the care of their
respective patients.
Methods
Settings
This study was part of the project MOSAR, a transdisciplinary
network devoted to combat and control of resistance in
bacteria [3]. This study was conducted from October 2008
until February 2011 in ﬁve RUs located in the north of France
(Berck Maritime Ho^pital, Berck, BM), and in areas of Rome,
Italy (Fondazione Santa Lucia, FSL), Barcelona, Spain (Gutt-
mann Institute, GI) and Tel-Aviv, Israel (Loewenstein Hospital,
LH; and Tel-Aviv Sourasky Medical Centre, TASMC); LH did
not participate in the FM part of the study. The units differ in
types of patients and size (BM, 80 beds; FS, 106 beds; GI, 38
beds; LH, 45 beds; TASMC, 50 beds). The policy regarding EPE
in these RUs included standard precautions only (e.g. hand
hygiene but without the use of gowns and gloves).
Study design and data collection
This was a prospective study, aimed at examining risk factors
for EPE carriage among HCWs and FMs of EPE-carrying
patients who agreed to participate. Rectal samples for culture
were collected from patients within 48 h of admission,
2 weeks later, then once monthly, and at discharge. Rectal
samples for culture were collected from FMs of EPE carriers
once during the hospital stay of their relatives, and those from
HCWs were collected in 3–4-point prevalence surveys, at
least once a year during this 30-month study.
Results from HCW rectal cultures were made available only
to the HCWs themselves and remained concealed from all
other hospital personnel, including the hospitals’ infection
control practitioners.
The following data were recorded: (i) patient demographics
—patient’s age and sex, medical history including underlying
conditions and comorbidities, previous hospital or long-term
care facility stay and its duration, antibiotic treatment during
the last month before admission, the presence of medical
devices, history of surgery or other invasive procedures and
the discharge destination; (ii) FM demographics—relationship
to patient, location, age and sex, previous hospital or
long-term care facility stay, antibiotic treatment during the
last month before patient’s admission, type and degree of
contact or shared activities with the patient; and (iii) HCW
details—location, profession, type and degree of contact with
the patients. The demographic and personal data were not
included in the HCW questionnaire, out of concern for their
conﬁdentiality and compliance with the study.
The study was approved by the ethics committees of all of
the centres.
Detection of EPE isolates and their phenotypic
characterization
Rectal swabs were streaked onto BrillianceTM ESBL Agar
(Oxoid, Basingstoke, UK). Putative EPE colonies (one per
morphotype) were identiﬁed according to the manufacturer’s
instructions. Pure cultures were frozen at 80°C and shipped
to the MOSAR ESBL Laboratory (National Medicines Institute,
Warsaw, Poland) for deﬁnite identiﬁcation and further analysis.
Species identiﬁcation was made using the Vitek 2 system
(bioMerieux, Marcy l’Etoile, France) and ESBL production was
veriﬁed as previously described [12].
Molecular typing of EPE isolates
Pulsed-ﬁeld gel electrophoresis (PFGE) was performed as
described [13], with the use of either XbaI (Fermentas, Vilnius,
Lithuania) for E. coli and Klebsiella pneumoniae or sequentially
NotI and SﬁI (New England BioLabs, Beverly, MA, USA) for
Proteus mirabilis [14]. The PFGE types and subtypes were
discerned visually according to the criteria of Tenover et al.
[15]. Multilocus sequence typing was performed for E. coli and
K. pneumoniae as described previously [16,17].
b-Lactamase analysis
b-Lactamase proﬁling was done by isoelectric focusing as
reported elsewhere [18]. The blaCTX-M-1-, blaCTX-M-2-,
blaCTX-M-9-, blaCTX-M-25-, blaSHV- and blaTEM-like genes were
identiﬁed using PCR [19]. Sequencing of the genes was
performed as reported elsewhere [19].
Deﬁnitions and data analysis
The EPE carrier patients were divided into ‘admission’ and
‘acquisition’ groups, according to the EPE identiﬁcation time:
before and after 72 h from admission, respectively. Strains of
EPE recovered from patients and their FMs were deﬁned as
identical when both were from the same species and shared
the same sequence type, PFGE type and ESBL gene.
As there was more than one FM per EPE-carrying patient,
the risk factors for EPE carriage among FMs were analysed by
two separate analyses, one concerning the FMs themselves,
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and one including the patients. In the second analysis, the
patients were divided into those with at least one EPE-positive
FM, and those without any EPE-positive FM.
Molecular characteristics of EPE isolates were compared
between patients and their respective FMs. Since transmission
of ESBL-producing E. coli between an individual patient and an
HCW is difﬁcult to prove, we compared the molecular
characteristics of HCW isolates with a large collection
(n = 376) of ESBL-producing E. coli isolates from patients
who were admitted to these RUs during the entire duration of
the study [20].
Data were analysed using univariate analysis: continuous
variables were compared between groups using an unpaired
t-test or the Spearman’s test for non-parametric correlations.
Categorical parameters were compared by using the Pearson v2
test. Values of p ≤0.05 were considered as signiﬁcant. Multivar-
iate analysis using logistic regression prediction models was
constructed using a forward stepwise procedure, entering all
variables with univariate p <0.1. All data were analysed using the
SPSS software package version 15.0 (SPSS, Chicago, IL, USA).
Results
Clinical characteristics of patients carrying EPE admitted to
rehabilitation wards
The study included 286 FMs of 194 EPE-carrying patients that
agreed to participate. EPE were detected upon admission in
144 (74.2%) of these patients and were acquired during the RU
stay in 50 (25.8%) patients. The clinical characteristics of these
patients, according to the carriage status of their respective
FMs, are presented in Table 1. The average age of patients was
65.9 years (range: 18–99), and 96 of them (49.5%) were males.
Almost all patients (98%) were admitted from another
healthcare facility. The EPE species identiﬁed in these patients
were E. coli (n = 134), K. pneumoniae (n = 84), P. mirabilis
(n = 49), Citrobacter spp. (n = 18), Enterobacter spp. (n = 16)
and others (n = 11).
Patient characteristics associated with carriage in their
respective FMs (p <0.1) were: hospitalization in GI versus
other centres, use of an invasive device in the last month
before admission, no antibiotic treatment upon admission, and
chronic lung disease. In multivariate analysis, admission to GI
(OR = 4, 95% CI 1.04–15.4, p 0.044) and chronic lung disease
(OR = 8.4, 95% CI 2.4–29.1, p 0.001) remained signiﬁcantly
associated with EPE carriage in FMs.
Carriage of EPE among family members of carrier patients
Data collection and ESBL surveillance culture were performed
on 286 FMs of the 194 known EPE-carrying patients (one to
eight FMs per patient). Their median age was 52 years (range
22–86 years; interquartile range 42.75–60.25 years). There
were 82 males (28.7%), and the relatives that were most
commonly surveyed were spouses (n = 64, 22.4%), employed
caregivers (n = 47, 16.4%), daughters (n = 47, 16.4%), moth-
ers (n = 38, 13.3%) and sons (n = 34, 11.9%).
EPE were detected in 26 (9.1%) FMs, related to 25 patients,
from GI, FS and TASMC (Table 2). EPE were detected in FMs
of 21 of 144 (14.6%) of the ‘admission’ group patients and 4 of
50 (8%) of the ‘acquisition’ group patients (p 0.221). Among
the EPE, E. coli was the most common (n = 20, 76.9%),
followed by K. pneumoniae (n = 5, 19.2%) and P. mirabilis
(n = 2, 7.7%); two FMs had mixed cultures of two EPE. The
EPE species recovered from the FMs were identical (at least
one species) to that recovered from their ESBL-carrying
relative for 23 of 26 (88%) FMs (Table 3).
Carriage of EPE among FMs was associated with female
gender (10.7% versus 2.4% in men), older age, hospitalization
within the last year, having a relative who is a patient
hospitalized in GI, Spain, longer daily median number of hours
spent with patient, sharing toilets with patients and bathing of
patients (Table 2). Also, EPE carriage was more common in
daughters or female spouses than in other relatives (15.8%
versus 5.4%, respectively, p 0.003) (Table 2). In multivariate
TABLE 1. Demographic and clinical characteristics of 194
extended spectrum b-lactamase-producing Enterobacteria-
ceae carriers hospitalized in rehabilitation wards, according
to the carriage status of their respective family members
Variable
EPE carriage in family member
p value
Carriers
(n = 25)
Non-carriers
(n = 169)
Male, n (%) 14 (56) 82 (48.5) 0.485
Age, years (95% CI) 67.2 (58.2–76.2) 65.6 (62.1–69.2) 0.751
Centre, n (%)
BM 0 2 (100) 0.048*
FSL 7 (9) 72 (91)
GI 4 (31) 9 (69)
TASMC 14 (14) 86 (86)
EPE acquisitiona, n (%) 4 (16) 46 (27) 0.221
Antibiotic on admission, n (%) 2 (8) 38 (22) 0.092
Antibiotic in past month, n (%) 15 (60) 84 (49) 0.252
Infection on admission, n (%) 4 (16) 24 (14) 0.808
Invasive device in
past month, n (%)
20 (83) 115 (68) 0.088
Surgery in past year, n (%) 18 (72) 104 (61) 0.188
Cardiovascular disease, n (%) 11 (44) 80 (47) 0.785
Congestive heart failure, n (%) 0 6 (3.5) 0.341
Chronic lung disease, n (%) 6 (24) 7 (4) <0.001
Diabetes, n (%) 4 (16) 20 (12) 0.451
Cerebrovascular disease, n (%) 4 (16) 27 (16) 0.974
Dementia, n (%) 0 11 (6.5) 0.190
Decubitus ulcer, n (%) 4 (15) 26 (15) 0.912
Discharge to home, n (%) 19 (76) 100 (59) 0.107
Abbreviations: BM, Berck Maritime Ho^pital, Berck, France; EPE, extended
spectrum b-lactamase-producing Enterobacteriaceae; FSL, Fondazione Santa Lucia,
Rome, Italy; GI, Guttmann Institute, Barcelona, Spain; TASMC, Tel-Aviv Sourasky
Medical Centre, Israel.
*p value for GI versus other centres.
aEPE carriage detected >72 h after admission.
ª2014 The Authors
Clinical Microbiology and Infection ª2014 European Society of Clinical Microbiology and Infectious Diseases, CMI, 20, O516–O523
O518 Clinical Microbiology and Infection, Volume 20 Number 8, August 2014 CMI
analysis, older age (OR = 1.04 per year, 95% CI 1–1.08,
p 0.022), longer mean number of hours spent with a patient
(OR = 1.09 per hour, 95% CI 1–1.19, p 0.036), and being a
daughter or a female spouse of a patient (OR = 5.11, 95% CI
1.74–15.05, p 0.003) remained signiﬁcantly associated with EPE
carriage by FMs.
Molecular analysis was performed on the 23 species-iden-
tical, patient–FM pairs of isolates, including two patients and
two FMs colonized by two different EPE organisms concur-
rently (Table 3). Nineteen of the pairs were E. coli (14.7% of all
ESBL-producing E. coli from patients), four were K. pneumoniae
(4.7%) and two were P. mirabilis (4.1%). Full molecular identity
was observed in 11 pairs (57.9%) of E. coli, and in all of the
K. pneumoniae and P. mirabilis pairs. The pandemic E. coli
ST131 clone was identiﬁed in 11 patients and nine FMs overall,
forming seven patient–FM pairs of indistinguishable isolates.
The remaining four such pairs comprised other widespread
E. coli sequence types, namely ST38, ST69, ST405 and ST617.
In all but one of the indistinguishable E. coli pairs, the ESBL type
produced was CTX-M-15. The K. pneumoniae pairs were
formed by pandemic clones ST15 (in GI) or ST147 (TASMC),
or a less frequently observed ST323 (TASMC), all of which
expressed CTX-M-15. The P. mirabilis pairs occurred in FSL
and TASMC, and produced TEM-92 and CTX-M-100, respec-
tively.
Carriage of ESBL-producing Enterobacteriaceae among
healthcare workers in rehabilitation centres
Data collection and ESBL surveillance culture were performed
during 3–4 point prevalence surveys (at least once a year) on
1001 HCWs in all ﬁve centres (Table 4). The HCW survey
enrolled 73 physicians, 288 nurses, 179 nursing assistants, 205
physical therapists, 37 janitors, 1 dietitian and 218 other staff
members. EPE were detected in 35 (3.5%; 95% CI 1.8–8.9%) of
the HCWs, including 34 E. coli and one Citrobacter freundii. The
risk factors for EPE carriage among HCWs are presented in
Table 4. In both the univariate and multivariate analyses, ESBL
carriage was more common among the Spanish GI employees
compared with other centres (OR = 3.78, 95% CI 1.38–10.3,
p 0.009), and in personnel involved in feeding patients
(OR = 2.02, 95% CI 1.01–4.04, p 0.046).
The molecular characteristics of 32 ESBL-producing E. coli
isolated from HCWs are shown in Table 5 (two isolates from
LH were omitted). ST131 was present in all of the RUs and
predominant overall (50.0%), being split into multiple PFGE
types and producing various CTX-M-type ESBLs. Most of the
other STs identiﬁed represented global E. coli clones, such as
ST10, ST23, ST38, ST69, ST155 or ST648, and were charac-
terized by diverse PFGE and ESBL types in different centres.
Almost all of the HCW strains produced CTX-Ms, mainly
CTX-M-1, -14 or -15. Only seven of the 23 ESBL-producing
E. coli subclones (each representing another combined
sequence type, PFGE and ESBL type), comprising 14 (43.8%)
HCW E. coli isolates, were also present among 376 random
patient-derived ESBL-producing E. coli isolates from the same
RUs (Table 5) [20]. Five of these were ST131 producing
CTX-M-14, -15 or -27.
Discussion
This study is the ﬁrst multinational report of ESBL carriage
among FMs and HCWs involved in the care of EPE-positive
TABLE 2. Risk factors for carriage of extended spectrum
b-lactamase-producing Enterobacteriaceae among 286 family
members of known carriers
Variable
Carriers
(n = 26)
Non-carriers
(n = 260) p value
Male, n (%) 2 (7.6) 80 (30.7) 0.022
Age, years (95% CI) 58.4 (52.4–64.3) 51.6 (50–53.3) 0.027
Centre, n (%)
BM 0 2 (100) 0.052
FSL 7 (5) 131 (95)
GIa 4 (22.2) 14 (77.8)
TASMC 15 (11.7) 113 (88.3)
Relation to patient, n (%) 0.204
Father 1 (5) 19 (95)
Mother 2 (5.3) 36 (94.7)
Son 1 (3) 33 (97)
Daughter 6 (12.8) 41 (87.2) 0.003b
Brother 0 6 (100)
Sister 0 6 (100)
Spouse, male 0 10 (100)
Spouse, female 10 (18.5) 44 (81.5) 0.003b
Caregiver 3 (6.4) 44 (93.6)
Other 3 (12.5) 21 (87.5)
Median duration
of ESBL
carriage before
FM survey, days
(25–75th centile)
21 (15–49) 31 (17–80) 0.309
Hospitalization
within 1 year
5 (19.2) 23 (8.8) 0.089
Recent (1 month)
use of antibiotics
2 (7.6) 15 (5.7) 0.63
Mean no. of visiting
days per week (95% CI)
6.2 (5.6–6.7) 6 (5.8–6.2) 0.61
Mean no. of visiting
hours per day (95% CI)
9 (6.3–11.7) 6.5 (5.9–7.1) 0.02
Shared household
with patient, n (%)
15 (57) 125 (48) 0.213
Shared bed with
patient (at home), n (%)
7 (27) 60 (23) 0.602
Shared bed with patient
(at rehabilitation
centre), n (%)
6 (23) 50 (19) 0.666
Shared toilet with
patient, n (%)
17 (65) 130 (50) 0.096
Feeding patients, n (%) 16 (61.5) 150 (57.6) 0.60
Bathing patients, n (%) 16 (61) 113 (43) 0.059
Dressing patients, n (%) 18 (69) 147 (56) 0.158
Contact with patient’s
excretions, n (%)
10 (38) 97 (37) 0.628
Assistance in wound
care, n (%)
7 (27) 50 (19) 0.33
Abbreviations: BM, Berck Maritime Ho^pital, Berck, France; EPE, extended
spectrum b-lactamase-producing Enterobacteriaceae; ESBL, extended spectrum
b-lactamase; FM, family member; FSL, Fondazione Santa Lucia, Rome, Italy; GI,
Guttmann Institute, Barcelona, Spain; TASMC, Tel-Aviv Sourasky Medical Centre,
Israel.
ap value for GI versus other centres: p 0.045.
bp value for daughter or wife versus other relatives.
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patients. This is also the ﬁrst study that combines the analysis
of epidemiological risk factors with molecular characterization
of colonizing organisms to examine ESBL carriage in FMs and
TABLE 3. Molecular characteristics of extended spectrum b-lactamase-producing Enterobacteriaceae strains isolated from
patients and their respective family members
Patient isolates Family member isolates
Centre Species ST PFGE type ESBL gene Species ST PFGE type ESBL gene
FSL E. coli ST131 FSEcoAI CTX-M-15 E. coli ST131 FSEcoAI CTX-M-15
E. coli ST69 FSEcoF CTX-M-15 E. coli ST69 FSEcoF CTX-M-15
E. coli ST131 FSEcoB CTX-M-15 E. coli ST131 FSEcoB CTX-M-15
E. coli ST131 FSEcoAI CTX-M-15 E. coli ST131 FSEcoAI CTX-M-15
E. coli ST131 FSEcoU CTX-M-15 E. coli ST131 FSEcoB CTX-M-15
E. coli ST131 FSEcoJ CTX-M-15 E. coli ST355 NTb CTX-M-1
P. mirabilis NAa FSPmiW TEM-92 P. mirabilis NA FSPmiW TEM-92
GI E. coli ST617 GIEcoY CTX-M-15 E. coli ST617 GIEcoY CTX-M-15
E. coli ST131 GIEcoAA CTX-M-15 E. coli ST131 GIEcoAA CTX-M-15
E. coli ST131 GIEcoAA CTX-M-15 E. coli ST131 GIEcoAA CTX-M-15
K. pneumoniae ST15 GIKpnJ CTX-M-15 K. pneumoniae ST15 GIKpnJ CTX-M-15
TASMC E. coli ST38 TAEcoAM CTX-M-15 E. coli ST38 TAEcoAM CTX-M-15
E. coli ST131 TAEcoI CTX-M-27 E. coli ST34 TAEcoBA CTX-M-15
E. coli ST405 TAEcoBZ CTX-M-14 E. coli ST405 TAEcoBZ CTX-M-14
E. colic ST648 NT CTX-M-14 E. colid ST216 TAEcoCA CTX-M-15
K. pneumoniaec ST147 TAKpnB CTX-M-15 K. pneumoniaed ST147 TAKpnB CTX-M-15
E. coli ST162 TAEcoCB SHV-12 E. coli ST405 TAEcoCC CTX-M-9
E. coli ST10 TAEcoCD SHV-12 E. coli ST117 NT SHV-12
E. coli ST131 TAEcoF CTX-M-15 E. coli ST131 TAEcoF CTX-M-15
E. coli ST398 TAEcoAS CTX-M-39 E. coli ST131 TAEcoB CTX-M-15
E. coli ST131 TAEcoCE CTX-M-27 E. coli ST69 TAEcoCF CTX-M-14
E. coli ST131 TAEcoE CTX-M-15 E. coli ST131 TAEcoE CTX-M-15
K. pneumoniae ST147 TAKpnB CTX-M-15 K. pneumoniae ST147 TAKpnB CTX-M-15
K. pneumoniaee ST323 TAKpnBE CTX-M-15 K. pneumoniaef ST323 TAKpnBE CTX-M-15
P. mirabilise NA TAPmiN CTX-M-100 P. mirabilisf NA TAPmiN CTX-M-100
Abbreviations: E. coli, Escherichia coli; ESBL, extended spectrum b-lactamase; FM, family member; FSL, Fondazione Santa Lucia, Rome, Italy; GI, Guttmann Institute, Barcelona,
Spain; K. pneumoniae, Klebsiella pneumoniae; PFGE, pulsed ﬁeld gel electrophoresis; P. mirabilis, Proteus mirabilis; ST, sequence type; TASMC, Tel-Aviv Sourasky Medical Centre,
Israel.
aNA, not applicable.
bNT, non-typeable.
c,d,e,fdenotes that the two ESBL-producing Enterobacteriaceae species were isolated from the same person.
TABLE 4. Risk factors for carriage of extended spectrum
b-lactamase-producing Enterobacteriaceae among healthcare
workers in ﬁve rehabilitation centres
Characteristics and
activities of HCW
Carriers
(n = 35)
Non-carriers
(n = 968) p value
Centre, n (%)
BM 3 (2) 144 (98) 0.05
FSL 12 (3) 427 (97)
GIa 5 (10.5) 42 (89.5)
LH 2 (3) 66 (97)
TASMC 13 (4.3) 287 (95.7)
Profession, n (%)
Physician 2 (2.7) 71 (97.3) 0.86
Nurse 13 (4.5) 275 (95.5)
Nurse’s assistant 7 (3.9) 172 (96.1)
Physical therapist 6 (3) 199 (97)
Janitor 2 (5.5) 35 (94.5)
Dietitian 0 1 (100)
Other 5 (2.3) 213 (97.7)
Involved in direct patient
contact, n (%)
31 (88.6) 882 (91.5) 0.545
Mean no. of patient’s contact
hours per week (95% CI)
28.3 (23.4–32.7) 29.3 (28.6–30.05) 0.613
Frequent contact with patient’s
excretions, n (%)
18 (51.4) 399 (41.3) 0.233
Frequent contact with patient’s
environment/equipment, n (%)
29 (82.9) 800 (82.8) 0.995
Feeding patients, n (%) 21 (60) 415 (43) 0.047
Bathing patients, n (%) 17 (48.6) 434 (45.1) 0.682
Dressing patients, n (%) 18 (51.4) 487 (50.7) 0.93
Changing patient’s
bedding, n (%)
19 (54.3) 456 (47.7) 0.423
Assistance in wound
care, n (%)
17 (48.6) 383 (39.8) 0.297
Assistance in CVC care, n (%) 13 (37.1) 319 (33.1) 0.617
Abbreviations: CVC, central venous catheters; ESBL, extended spectrum
b-lactamase; FSL, Fondazione Santa Lucia, Rome, Italy; GI, Guttmann Institute,
Barcelona, Spain; HCW, healthcare worker; LH, Loewenstein Hospital, Tel-Aviv,
Israel; TASMC, Tel-Aviv Sourasky Medical Centre, Israel.
2p value for GI versus other centres: p 0.006.
TABLE 5. Molecular characteristics of extended spectrum
b-lactamase-producing Escherichia coli strains isolated from
healthcare workers
Centre ST ESBL gene PFGE types Strains No. Patients?a
BM 131 CTX-M-14 1 1 Y
10 CTX-M-1 1 1 N
23 TEM-52 1 1 N
FSL 131 CTX-M-15 2 6 Y
CTX-M-27 1 1 N
38 CTX-M-14 1 1 N
69 CTX-M-15 1 1 N
155 CTX-M-1 NTb 1 Y
648 CTX-M-15 1 1 N
2485 CTX-M-1 NT 1 N
GI 10 CTX-M-14 1 1 N
SHV-12 1 1 N
131 CTX-M-15 1 2 N
648 CTX-M-115 1 1 N
TASMC 131 CTX-M-27 1 4 Y
CTX-M-15 1 1 Y
1 1 N
1284 CTX-M-15 1 2 N
69 CTX-M-14 1 1 Y
38 CTX-M-14 1 1 N
398 CTX-M-15 1 1 N
453 SHV-12 1 1 N
Abbreviations: ESBL, extended spectrum b-lactamase; FSL, Fondazione Santa
Lucia, Rome, Italy; GI, Guttmann Institute, Barcelona, Spain; PFGE, pulsed ﬁeld gel
electrophoresis; ST, sequence type; TASMC, Tel-Aviv Sourasky Medical Centre,
Israel.
aRefers to the presence (Y) or absence (N) of an identical strain (identical ST,
PFGE and ESBL gene types) in patients’ isolates from the same institution.
bNT, not typeable.
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HCWs and its relatedness to interactions with carrier
patients. The sources of acquisition in these populations can
be deﬁned as either occupation-related (i.e. related to caring
for other patients), healthcare-related (i.e. related to health-
care acquisition while being patients) or community acquired.
The healthcare-related acquisition is the least likely, as only
ﬁve of the 26 FM carriers (19.2%) had been hospitalized in the
last year. Community-related acquisition of EPE, most prom-
inently of the ST131 E. coli clone [4], has been the focus of
intense research during the last decade. In addition to contact
with other ESBL carriers in the community setting [9,11],
other factors, such as contaminated food [21] or pets [22]
were implicated as potential sources. As we learned in this
study, the sources for EPE are likely to be different in HCWs
versus FMs.
Carriage of EPE in HCWs was found in 35 of 1001 (3.5%)
persons, almost all of them carrying ESBL-producing E. coli.
This rate is much lower than the 14.5% rate that was reported
from an Italian long-term care facility staff [23], including when
compared with the rate found in the Italian RU that
participated in our study (2.7%). The difference may be
explained in part by different patient populations; moreover,
as the earlier study [23] comprised a much smaller number of
participating staff (n = 69) and did not include any epidemi-
ological data, further comparisons are not possible. Our
HCW risk factor analysis identiﬁed two factors. The ﬁrst,
related to the Barcelona centre GI, might be a reﬂection of
the overall carriage rate in either the patients or the general
population in that area. Our preliminary unpublished data
from the MOSAR project indicate that indeed, the EPE
carriage upon admission to the RUs was highest in GI (39.6
versus 28.5% in all other centres). The second risk factor was
related to participation in patient feeding. As other activities
associated with even more intense contact were not related
to carriage, this ﬁnding may suggest that food itself might be
implicated in the transmission of EPE, perhaps both to staff
and patients. Indeed, a recent study found a high rate of EPE in
retail meat in Spain [24]. In our study, molecular character-
ization of HCW EPE strains showed a highly diverse E. coli
population that included 23 distinct subclones, of which only
seven were also identiﬁed in the respective patient popula-
tions [20]. Moreover, among the shared subclones, ﬁve were
of the pandemic ST131 clone, with various ESBL types. As
ST131 is the most common E. coli clone identiﬁed in both the
community and the healthcare settings [4], it is difﬁcult to
assert whether its presence in an HCW represents a
healthcare or community acquisition. Overall, the comparative
molecular analysis of EPE strains from patients and HCWs
suggests that most of the latter were not the result of
patient-related acquisition.
Among FMs, EPE were detected in 26 of 286 (9.1%)
individuals, a lower rate when compared with 16.7% found
among household contacts of infected patients [11]. The risk
factors analysis shows that both patient-related and FM-related
factors may be important. Carriage was more common in
older FMs and in Barcelona, GI, suggesting both personal and
local factors that were patient-independent. On the other
hand, carriage was also related to the time spent with patients
and to chronic lung disease in the patient. It was also more
common in female spouses or daughters, possibly reﬂecting
the more intense involvement of these FMs in the care of their
relatives. In accordance with the epidemiological data, the
molecular analysis strongly suggests the importance of
intra-familial spread of EPE, since: (i) the EPE species was
identical in the patients and their FM (in at least one species) in
23 of 26 EPE-positive FMs and (ii) 11 of 19 (57%) E. coli and
all K. pneumoniae and P. mirabilis pairs of isolates were of
identical subclones. Hence, our results strongly suggest that
patient-related transmission is more signiﬁcant for FMs than
for HCWs.
The higher risk of patient-related EPE acquisition by FMs
when compared with HCWs may be explained by the
intensity, duration (during and beyond the hospitalization),
and types of contact (e.g. sharing food, hugging). These ﬁndings
differ from those regarding methicillin-resistant S. aureus,
which showed transmission in both the community settings
[7] to FMs and other contacts, as well as to (and from) HCWs
[25,26] in the healthcare settings. The difference between
methicillin-resistant S. aureus and EPE may be a result of their
different colonization sites, degree of environmental surviv-
ability or other unclear biological factors. There are only
limited data regarding the transmission risk for other
multi-resistant organisms. A single study on vancomycin-resis-
tant enterococci, found evidence for transmission to both FMs
and HCWs from vancomycin-resistant enterococci-positive
patients, but the number of cases was too small to allow any
conclusions to be drawn on the risk factors.
Our study has several limitations. (i) As FMs were screened
only once, we cannot determine the direction of transmission
between patients and FMs. (ii) As a result of conﬁdentiality
considerations, personal data were not obtained from HCWs,
which limited our ability to identify personal factors related to
the EPE carriage. (iii) As direct patient–HCW pairing was
impossible, we compared HCW isolates with an extensive
collection of patients’ EPE isolates (n = 376) identiﬁed
throughout the study in the same RUs [20]; transmission to
HCWs may also have occurred from other patients that were
not included in the study. (iv) Finally, as this study was
conducted in different countries, it is possible that local
factors, unrelated to the institution itself, might have played an
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important role, especially in GI. Notwithstanding these limi-
tations, our study provides a unique perspective based on both
epidemiological and molecular data, regarding the transmission
risk of EPE in both HCWs and FMs. Our results strongly
suggest that FMs are at higher risk of EPE acquisition from their
relative patients than HCWs.
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Appendix 1
The MOSAR WP5 and WP2 study groups:
A. Grabowska, M. Herda, E. Nikonorow—National Medicines
Institute, Warsaw, Poland; M. J. Schwaber, E. Bilavsky, M.
Elenbogen, A. Klein, S. Navon-Venezia, M. Shklyar, L. Keren, R.
Glick, S. Klarfeld-Lidji, S. Cohen, R. Fachima, Y. Zdonevsky, B.
Knubovets—Division of Epidemiology; A. Rabinovich, Wasef
Naamnih, Basanda Suonov—Geriatric Division, both from the
Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel; J. Lasley, I.
Bertucci, M.-L. Delaby, C. Colmant, C. Sacleux—Ho^pital
Maritime de Berck, Berck/Garches/Paris, France; R. Formisano,
M. P. Balice, E. Guaglianone—Fondazione Santa Lucia IRCCS,
Rome, Italy; S. Camps—Institute Guttmann, Barcelona, Spain; J.
Hart, E. Isakov, A. Friedman, A. Rachman, G. Franco, I. Or—
Loewenstein Hospital, Ra’anana, Israel.
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